Aravive, Inc. (ARAV) News Headlines

▮ More

Date

Headline

11/19/2020 7:19:27 AM Aravive Receives Guidance From FDA On Phase 3 Trial Design For AVB-500

9/17/2020 7:07:12 AM Aravive Appoints Michael Rogers To Board

9/15/2020 7:27:26 AM Aravive Appoints Reshma Rangwala As Chief Medical Officer

4/9/2020 7:14:13 AM Aravive Announces Board Changes; Names Gail McIntyre CEO

12/20/2019 8:24:46 AM Aravive Begins Phase 2a Trial Of AVB-500 In Patients With Kidney Fibrosis

11/27/2019 8:48:40 AM Aravive Prices Public Offering Of 3.33 Mln Shares At $7.50/Shr

9/21/2019 7:03:07 AM Week Ahead In Pharma: 9 Stocks To Watch (AVXL, GMAB, ARAV…)

9/19/2019 9:39:05 PM 6 Top Gainers In Healthcare Sector (AIM, EDSA, ARAV…)

9/18/2019 10:38:56 PM 5 Top Gainers In Healthcare Sector (LXRX, ECOR, ARAV…)

7/31/2019 9:07:34 PM 5 Top Gainers In Healthcare Sector (ARAV, NBSE, SESN…)

7/8/2019 7:10:11 AM Aravive: Independent Data Monitoring Committee Recommends Continuation Of Phase Ib Study Of AVB-500

7/8/2019 7:08:50 AM Aravive Says IDMC Recommends Continuation Of Phase Ib Study Of AVB-500

4/29/2019 9:23:10 PM 7 Top Gainers In Pharma Sector (ATHE, NSPR, NCNA…)

3/7/2019 4:13:00 PM Aravive Q4 Loss/share $4.82 Vs. Profit $5.20 Year Ago

Older Articles Latest Headlines